Fig. 3
From: Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis
Relative brain-enriched protein quantification and subsequent disease progression. This includes only proteins with statistically significant difference between relative protein quantification of controls, patients who did not reach an EDSS of 4, and patients who did reach an EDSS score of 4 after throughout the follow-up time (Kruskal-Wallis p-values; CADM2 p = 0.027, CAMK2A p = 0.0028, CBLN2 p = 0.0091, CNTNAP4 p = 0.0050, CSPG5 p = 0.0091, KLK6 p = 0.0155, LINGO1 p = 0.0109, LRRC4B p = 0.0122, OPCML p = 0.0109). Lines and boxes depict median and interquartile range, and bars represent total range